Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $28.71 $35.40 Friday, 10th May 2024 AGIO stock ended at $33.00. This is 0.243% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 1.97% from a day low at $32.45 to a day high of $33.09.
90 days $24.69 $35.48
52 weeks $19.80 $35.48

Historical Agios Pharmaceuticals prices

Date Open High Low Close Volume
Oct 21, 2016 $49.12 $49.12 $49.12 $49.12 702 700
Oct 20, 2016 $50.33 $50.33 $50.33 $50.33 543 500
Oct 19, 2016 $48.32 $48.32 $48.32 $48.32 337 900
Oct 18, 2016 $49.26 $49.26 $49.26 $49.26 485 400
Oct 17, 2016 $47.52 $47.52 $47.52 $47.52 541 300
Oct 14, 2016 $47.78 $47.78 $47.78 $47.78 711 700
Oct 13, 2016 $50.72 $50.72 $50.72 $50.72 533 900
Oct 12, 2016 $50.45 $50.45 $50.45 $50.45 583 100
Oct 11, 2016 $53.26 $53.26 $53.26 $53.26 398 200
Oct 10, 2016 $55.02 $55.02 $55.02 $55.02 367 500
Oct 07, 2016 $52.69 $52.69 $52.69 $52.69 619 100
Oct 06, 2016 $53.80 $53.80 $53.80 $53.80 589 500
Oct 05, 2016 $54.40 $54.40 $54.40 $54.40 383 500
Oct 04, 2016 $53.30 $53.30 $53.30 $53.30 460 500
Oct 03, 2016 $52.84 $52.84 $52.84 $52.84 441 300
Sep 30, 2016 $52.82 $52.82 $52.82 $52.82 572 800
Sep 29, 2016 $51.82 $51.82 $51.82 $51.82 700 900
Sep 28, 2016 $54.21 $54.21 $54.21 $54.21 546 800
Sep 27, 2016 $54.55 $54.55 $54.55 $54.55 369 100
Sep 26, 2016 $52.70 $52.70 $52.70 $52.70 364 100
Sep 23, 2016 $53.03 $53.03 $53.03 $53.03 798 900
Sep 22, 2016 $53.03 $53.03 $53.03 $53.03 842 500
Sep 21, 2016 $52.29 $52.29 $52.29 $52.29 947 300
Sep 20, 2016 $49.83 $49.83 $49.83 $49.83 1 099 100
Sep 19, 2016 $47.57 $47.57 $47.57 $47.57 684 000
Click to get the best stock tips daily for free!

About Agios Pharmaceuticals

Agios Pharmaceuticals Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph... AGIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT